StockData
Kura Oncology, Inc. logo

Kura Oncology, Inc. (KURA) stock

KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$6.91−0.44 (-5.99%)

Close on Nov 20, 2026Market cap $614.72MP/E –Yield –

Kura Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kura Oncology's market cap was $687.61M on Nov 11, 2026, against $1.06B a year earlier. Over the last 5 years it ranged from $459.63M to $1.61B, with a median of $905.38M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$687.61M-23.9%
2025Dec 31, 2025$904.10M+33.5%
2024Dec 31, 2024$677.19M-36.6%
2023Dec 29, 2023$1.07B+28.6%
2022Dec 30, 2022$830.15M-10.8%
2021Dec 31, 2021$931.06M-49.7%
2020Dec 31, 2020$1.85B+196.9%
2019Dec 31, 2019$622.83M+16.7%
2018Dec 31, 2018$533.72M+19.8%
2017Dec 29, 2017$445.64M+296.6%
2016Dec 30, 2016$112.37M+22.3%
2015Dec 31, 2015$91.86M–

More Kura Oncology figures

See a number that looks wrong?